Literature DB >> 8135471

The clinical importance of DNA synthesis and aneuploidy in bone and soft tissue tumours.

A Alho1, S Skjeldal, J E Melvik, E O Pettersen, T E Larsen.   

Abstract

DNA flow cytometric analysis including the analysis of S-phase fraction was performed on 46 bone and soft tissue tumours. Histologically, 24 lesions were benign, 11 were low grade and 11 were high grade malignant tumours. The percentages of aneuploidy in these groups were 29, 54 and 82, respectively. The S-phase fraction was smaller than 14% in all benign tumours. High S-phase fraction (> or = 14%) was found in 3 out of 11 low-grade tumours (27%) and in 9 out 11 high-grade tumours (82%). Seven of nine patients who died of metastatic disease during the average 5 year follow-up had aneuploid stemlines with S-phase fraction higher than 14%. Histologically, these were all high-grade tumours. Three patients with high S-phase in low-grade tumours survived. We conclude that high DNA synthetic activity in an aneuploid population, more than the DNA aneuploidy alone, has prognostic significance in musculoskeletal tumours.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8135471

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.

Authors:  P Rudolph; U Kellner; A Chassevent; F Collin; F Bonichon; R Parwaresch; J M Coindre
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

2.  Gadd45β expression in chondrosarcoma: a pilot study for diagnostic and biological implications in histological grading.

Authors:  Michihisa Zenmyo; Akihide Tanimoto; Harutoshi Sakakima; Masahiro Yokouchi; Satoshi Nagano; Takuya Yamamoto; Yasuhiro Ishido; Setsuro Komiya; Kosei Ijiri
Journal:  Diagn Pathol       Date:  2010-10-13       Impact factor: 2.644

3.  Flow cytometric S-phase fraction in soft-tissue sarcoma: prognostic importance analysed in 160 patients.

Authors:  P Gustafson; M Fernö; M Akerman; B Baldetorp; H Willén; D Killander; A Rydholm
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Prognostic markers in chondrosarcoma: evaluation of cell proliferation and of regulators of the cell cycle.

Authors:  S P Scully; L J Layfield; J M Harrelson
Journal:  Sarcoma       Date:  1997
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.